Hunter Perkins Capital Management, LLC / BMY
Hunter Perkins Capital Management, LLC’s Bristol-Myers Squibb Co Position
Does Hunter Perkins Capital Management, LLC own Bristol-Myers Squibb Co (BMY)? Not currently — the last reported position was 78.1K shares worth $5M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q1 2025
Shares
78.1K
% of Portfolio
+1.11%
Quarters Held
14
position exited
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 78.1K | $5M | +1.11% |
| Q4 2024 | 178.6K | $10M | +2.12% |
| Q3 2024 | 197.6K | $10M | +2.07% |
| Q2 2024 | 55.0K | $2M | +0.48% |
| Q1 2024 | 56.0K | $3M | +0.62% |
| Q4 2023 | 58.8K | $3M | +0.63% |
| Q3 2023 | 94.2K | $5M | +1.17% |
| Q2 2023 | 132.9K | $5M | +1.14% |
| Q1 2023 | 49.2K | $3M | +0.80% |
| Q4 2022 | 46.3K | $3M | +0.75% |
| Q3 2022 | 77.4K | $6M | +1.35% |
| Q2 2022 | 79.5K | $6M | +1.42% |
| Q1 2022 | 128.1K | $9M | +1.88% |
| Q4 2021 | 110.9K | $7M | +1.30% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hunter Perkins Capital Management, LLC’s full portfolio or all institutional holders of BMY.